Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-22-010447

Chief Executive Officer acquired 179,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Conterno Enrique A Chief Executive Officer 2022-02-14 Grant or award +179,400 312,104 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Conterno Enrique A Chief Executive Officer 2022-02-14 Grant or award · Stock Option (Right to Buy) +298,000 298,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…